Nov 26, 2024 | Alternative Reimbursement Strategies, Case Studies, Cost Savings, Direct-to-Employer Contracting, Health care costs, Savings
From Benefits Pro: “According to the 2024 Best Practices in Healthcare Survey from WTW, more than half of employers plan to implement programs that will reduce total costs, and just as many intend to adopt plan design and network strategies that steer workers to...
Oct 29, 2024 | Alternative Reimbursement Strategies, Chronic conditions, Client Report, Cost projections, Cost Savings, Direct-to-Employer Contracting, Drug costs, Fair market reimbursement, Forensic claims review, Health care costs, High-cost claims, MedBen Rx, MedBen WellLiving, Prescription, Rx Costs, Transparency, Trend, Wellness
Health care costs in the United States are projected to see their steepest rise in over a decade during 2025, with multiple industry analyses forecasting increases between 7% and 8% year-over-year (see table below). However, MedBen offers solutions that directly...
Sep 13, 2024 | Cancer, Health care costs, Heart disease, High-cost claims, Mental Health, Rx Costs, Survey
Employers say they expect their health care costs to rise 7.8% next year — the highest estimate in more than 15 years — according to the latest Business Group on Health member survey. Even factoring in cost-reducing plan design changes, respondents project costs to...
Aug 1, 2024 | Cost Savings, Debit Cards, Flexible spending accounts (FSAs), FSA Store, Health care costs, Health flexible spending account (FSA), Savings
Offering your plan members a flexible spending account (FSA) option is not only an effective way to help them lower their health care spend (qualified purchases are made using tax-free dollars), but by adding a MedBen debit card, it’s a convenient way to do it!...
Mar 19, 2024 | Asthma, Blood pressure, Cholesterol, Chronic conditions, Cost Savings, Diabetes, Health care costs, Heart, Hypertension, MedBen WellLiving, Savings, Wellness, Wellness exam, Wellness screenings
The cost of five major chronic conditions, in physical and financial terms: Cardiovascular disease (CVD) is the leading cause of death in the United States, and cost the U.S. $407.3 billion between 2018 to 2019.Between 2017 and 2020, 10% of adults age 20 or...
Mar 18, 2024 | DNA, Drug costs, Drugmakers, Gene therapy, Health care costs, Rx Costs, Spending
Back in late 2022, MedBen spotlighted the growth of gene therapy, a transformative medical approach that potentially cures genetic disorders by correcting or replacing an individual’s DNA. As we noted, these therapies go beyond treatment to literally...
